Full List Of Stories
MyCelx raises revenue forecasts after new orders
Clean water technology company MyCelx Technologies Corporation has secured a new purchase order in Saudi Arabia, and has sold equipment in Australia, it announced on Thursday.
RhythmOne prepares shareholders for bumper results
RhythmOne issued a preliminary update on its expected performance for the full year ended 31 March on Thursday, confirming it was in-line with expectations.
Sunrise Resources posts results from Baker's Gold exploration
Sunrise Resources updated the market on the results of exploration it recently carried out at its Baker's Gold Project in Western Australia on Thursday.
Mpac trading in line as chairman steps down
Packaging company Mpac Group told investors that trading in its first quarter was ahead of last year and in line with the board’s expectations on Thursday, as they gathered for the annual general meeting.
Gattaca shares tank as telecoms business continues to disappoint
Specialist engineering and technology recruitment business Gattaca watched its shares fall through the floor on Thursday, after it announced its interim results for the six months ended 31 January, with diluted earnings per share down 25%.
Acacia Mining production and revenue fall in first quarter
Acacia Mining issued its first-quarter results on Thursday, reporting that its production tracked full-year guidance during the period, whilst all three operations delivered in line with their respective mine plans.
CEO of hVIVO steps down as profits fall
Clinical development and drug discovery services firm hVIVO announced on Thursday that Kym Denny is stepping down as chief executive, with immediate effect.
Bluefield Solar sticks to dividend targets, buys Dorset assets
UK-based solar asset investor Bluefield Solar announced its second interim dividend for the financial year ending 30 June on Thursday.
Asia report: Markets boosted by US earnings, Japan trade talks
Markets in Asia finished in the green on Thursday, as investors cheered another solid session amid a strong earnings season in the US overnight, and oil prices continued to climb.
Enlarged AVEVA Group trades in line at year-end
Engineering and industrial software AVEVA Group updated the market on its financial year ended 31 March on Thursday, based on unaudited results, with revenue for the enlarged group expected to be in-line with the board's expectations.
GlaxoSmithKline and Innoviva publish positive new IMPACT data
GlaxoSmithKline, alongside Nasdaq-listed partner Innoviva, announced the publication of the landmark IMPACT study - one of the biggest ever conducted in patients with chronic obstructive pulmonary disease with a history of exacerbation - in the New England Journal of Medicine on Thursday.
BHP lowers guidance for copper and iron ore production
BHP Billiton posted its operational review for the nine months ended 31 March on Thursday, confirming that its full-year production guidance remained unchanged for petroleum, metallurgical coal and energy coal.
FDA gives AstraZeneca's Tagrisso the thumbs up for first-line treatment
AstraZeneca announced on Thursday that the US Food and Drug Administration has approved Tagrisso (osimertinib) for the first-line treatment of patients with metastatic non-small cell lung cancer, whose tumours have epidermal growth factor receptor mutations as detected by an FDA-approved test.